Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung 
Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

Kuester, Miriam M.; Schneider, Marc A.; Richter, Antje M.; Richtmann, Sarah; Winter, Hauke; Kriegsmann, Mark; Pullamsetti, Soni S.; Stiewe, Thorsten; Savai, Rajkumar; Muley, Thomas; Dammann, Reinhard H.

doi:10.3390/cancers12123528

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis

MPS-Authors

/persons/resource/persons248833

Richter, Antje M.
Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224324

Pullamsetti, Soni S.
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224330

Savai, Rajkumar
Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kuester, M. M., Schneider, M. A., Richter, A. M., Richtmann, S., Winter, H., Kriegsmann, M., et al. (2020). Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis. CANCERS, 12(12): 3528. doi:10.3390/cancers12123528.

Cite as: https://hdl.handle.net/21.11116/0000-0007-AE68-1

Abstract

There is no abstract available